Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In Elevance (ELV) To Contact Him Directly To Discuss Their Options If you are a long-term ...

P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In Elevance (ELV) To Contact Him Directly To Discuss Their Options ...

Health-care companies fell as a flight from health insurers continued. Shares of UnitedHealth Group fell 2.9% and are now down 42% for the year to date. Humana slipped 2.4%. Elevance Health shares ...

Health insurer Elevance Health Inc. (NYSE:ELV) is scheduled to release its second quarter 2025 financial results on July 17. Analysts estimate adjusted earnings of $9.197 per share on sales of $48.24 ...

Analysts generally have a positive outlook for Elevance Health, with an ‘Outperform’ consensus rating and a decent potential ...

Analysts’ consensus projections for Elevance Health's forthcoming report indicate earnings of $9.19 per share on revenue of ...

Ten analysts recently shared bullish-to-bearish takes on Elevance Health over the last three months, leaning heavily bullish.

The 12-month price targets assessed by analysts reveal further insights, featuring an average target of $484.4, a high estimate of $522.00, and a low estimate of $434.00. A negative shift in sentiment ...

Elevance Health, Inc. ELV is set to report its second-quarter 2025 results on July 17, 2025, before the opening bell. The ...

Health insurance companies have pledged to improve prior authorization with 6 key reforms, according to the HHS.

Wall Street analysts forecast that Elevance Health (ELV) will report quarterly earnings of $9.20 per share in its upcoming release, pointing to a year-over-year decline of 9.1%. It is anticipated that ...

Analysts have given Elevance Health a consensus rating of “Moderate Buy,” with twelve of sixteen recommending purchase and ...